Skip to main content
. 2022 Oct 31;9:1052943. doi: 10.3389/fmed.2022.1052943

Figure 5.

Figure 5

Forest plots of the association between SII and adverse clinicopathology in nmPCa: (A) pathological tumor stage ≥3, (B) pathological lymph node stage ≥1, (C) Gleason score ≥7, and (D) positive surgical margins. SII, systemic immune-inflammation index; nmPCa, non-metastatic prostate cancer.